Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""prognosis"" wg kryterium: Temat


Starter badań:

Tytuł:
Prognostic models: What the statistician wants the clinician to know.
Autorzy:
Allen E; Statistics and Clinical Research, NHS Blood and Transplant, Fox Den Road, Stoke Gifford, BS36 8RR, UK. Electronic address: .
Robb ML; Statistics and Clinical Research, NHS Blood and Transplant, Fox Den Road, Stoke Gifford, BS36 8RR, UK. Electronic address: .
Pokaż więcej
Źródło:
Best practice & research. Clinical gastroenterology [Best Pract Res Clin Gastroenterol] 2023 Dec; Vol. 67, pp. 101872. Date of Electronic Publication: 2023 Oct 09.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Prognosis*
Models, Statistical*
Humans
Czasopismo naukowe
Tytuł:
Prognostic models - Their use and abuse.
Autorzy:
Neuberger J; Liver Unit, Queen Elizabeth Hospital, Birmingham, B15 2TH, UK. Electronic address: .
Fuccio L; Department of Medical and Surgical Sciences and University of Bologna, 2IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico S.Orsola, Bologna, Italy.
Pokaż więcej
Źródło:
Best practice & research. Clinical gastroenterology [Best Pract Res Clin Gastroenterol] 2023 Dec; Vol. 67, pp. 101868. Date of Electronic Publication: 2023 Sep 08.
Typ publikacji:
Editorial
MeSH Terms:
Prognosis*
Models, Statistical*
Humans
Opinia redakcyjna
Tytuł:
Multimodal prognostic models and recent therapeutic advances.
Autorzy:
Minervini A; Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy. Electronic address: .
Mari A; Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy.
Pokaż więcej
Źródło:
The Lancet. Digital health [Lancet Digit Health] 2023 Aug; Vol. 5 (8), pp. e482-e483. Date of Electronic Publication: 2023 Jun 29.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Prognosis*
Czasopismo naukowe
Tytuł:
Clinical predictive models in equine medicine: A systematic review.
Autorzy:
Cummings CO; Tufts Clinical and Translational Science Institute, Tufts Medical Center, Boston, Massachusetts, USA.
Krucik DDR; Department of Comparative Medicine, Stanford University, California, USA.
Price E; Tufts Clinical and Translational Science Institute, Tufts Medical Center, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Equine veterinary journal [Equine Vet J] 2023 Jul; Vol. 55 (4), pp. 573-583. Date of Electronic Publication: 2022 Nov 08.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Prognosis*
Horses ; Animals ; Bias
Czasopismo naukowe
Tytuł:
A deep learning model for accurately predicting cancer-specific survival in patients with primary bone sarcoma of the extremity: a population-based study.
Autorzy:
Cheng D; Department of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Liu D; Department of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Li X; Department of Orthopaedics, Shenzhen University General Hospital, Shenzhen, 518052, China.
Mi Z; Department of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Zhang Z; Department of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Tao W; Department of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Dang J; Department of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Zhu D; Department of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Fu J; Department of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Fan H; Department of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China. .
Pokaż więcej
Źródło:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Mar; Vol. 26 (3), pp. 709-719. Date of Electronic Publication: 2023 Aug 08.
Typ publikacji:
Journal Article
MeSH Terms:
Deep Learning*
Sarcoma*/pathology
Bone Neoplasms*/secondary
Osteosarcoma*/therapy
Osteosarcoma*/pathology
Humans ; Prognosis ; Extremities/pathology ; Nomograms
Czasopismo naukowe
Tytuł:
Prognostic value of GLIM-defined malnutrition in combination with hand-grip strength or gait speed for the prediction of postoperative outcomes in gastric cancer patients with cachexia.
Autorzy:
Li, Zong-Ze (AUTHOR)
Yan, Xia-Lin (AUTHOR)
Zhang, Zhao (AUTHOR)
Chen, Jiong-Lai (AUTHOR)
Li, Jiang-Yuan (AUTHOR)
Bao, Jing-Xia (AUTHOR)
Ru, Jia-Tong (AUTHOR)
Wang, Jia-Xin (AUTHOR)
Chen, Xiao-Lei (AUTHOR)
Shen, Xian (AUTHOR)
Huang, Dong-Dong (AUTHOR)
Pokaż więcej
Źródło:
BMC Cancer. 2/23/2024, Vol. 24 Issue 1, p1-11. 11p.
Czasopismo naukowe
Tytuł:
Improving shared decision-making about cancer treatment through design-based data-driven decision-support tools and redesigning care paths: an overview of the 4D PICTURE project.
Autorzy:
Rietjens, Judith A. C. (AUTHOR)
Griffioen, Ingeborg (AUTHOR)
Sierra-Pérez, Jorge (AUTHOR)
Sroczynski, Gaby (AUTHOR)
Siebert, Uwe (AUTHOR)
Buyx, Alena (AUTHOR)
Peric, Barbara (AUTHOR)
Svane, Inge Marie (AUTHOR)
Brands, Jasper B. P. (AUTHOR)
Steffensen, Karina D. (AUTHOR)
Romero Piqueras, Carlos (AUTHOR)
Hedayati, Elham (AUTHOR)
Karsten, Maria M. (AUTHOR)
Couespel, Norbert (AUTHOR)
Akoglu, Canan (AUTHOR)
Pazo-Cid, Roberto (AUTHOR)
Rayson, Paul (AUTHOR)
Lingsma, Hester F. (AUTHOR)
Schermer, Maartje H. N. (AUTHOR)
Steyerberg, Ewout W. (AUTHOR)
Pokaż więcej
Źródło:
Palliative Care & Social Practice. 2/12/2024, p1-15. 15p.
Czasopismo naukowe
Tytuł:
Preoperative albumin-alkaline phosphatase ratio affects the prognosis of patients undergoing hepatocellular carcinoma surgery.
Autorzy:
Huang, Wei (AUTHOR)
Wei, Suosu (AUTHOR)
Dong, Xiaofeng (AUTHOR)
Tang, Yuntian (AUTHOR)
Tang, Yi (AUTHOR)
Liu, Hongjun (AUTHOR)
Huang, Junzhang (AUTHOR)
Yang, Jianrong (AUTHOR)
Pokaż więcej
Źródło:
Cancer Biomarkers. 2024, Vol. 39 Issue 1, p15-26. 12p.
Czasopismo naukowe
Tytuł:
Clinical Implications and Prognostic Value of Leucine-Rich G Protein-Coupled Receptor 5 Expression as A Cancer Stem Cell Marker in Malignancies: A Systematic Review and Meta-Analysis.
Autorzy:
Ghobakhloo, Sepideh
Khoshhali, Mehri
Vatandoost, Nasimeh
Jafarpour, Sima
Niazmand, Anoosha
Nedaeinia, Reza
Salehi, Rasoul
Pokaż więcej
Źródło:
Cell Journal (Yakhteh). Jan2024, Vol. 26 Issue 1, p1-12. 12p.
Czasopismo naukowe
Tytuł:
Exosome-Related FTCD Facilitates M1 Macrophage Polarization and Impacts the Prognosis of Hepatocellular Carcinoma.
Autorzy:
Liu, Youyi (AUTHOR)
Tang, Yifei (AUTHOR)
Jiang, Hongliang (AUTHOR)
Zhang, Xiading (AUTHOR)
Chen, Xingyi (AUTHOR)
Guo, Jingrou (AUTHOR)
Jin, Cheng (AUTHOR)
Wu, Minchen (AUTHOR)
Pokaż więcej
Źródło:
Biomolecules (2218-273X). Jan2024, Vol. 14 Issue 1, p41. 17p.
Czasopismo naukowe
Tytuł:
Pitfalls of the concordance index for survival outcomes.
Autorzy:
Hartman N; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
Kim S; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, Seoul, Republic of Korea.
He K; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
Kalbfleisch JD; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
Pokaż więcej
Źródło:
Statistics in medicine [Stat Med] 2023 Jun 15; Vol. 42 (13), pp. 2179-2190. Date of Electronic Publication: 2023 Mar 28.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Prognosis*
Humans ; Probability ; Survival Analysis
Czasopismo naukowe
Tytuł:
Clinical features and prognosis of Tibetan patients with neuromyelitis optica spectrum disorder are different from those of Han Chinese patients.
Autorzy:
Luo W; Department of Neurology, West China Hospital, Sichuan University, No.37 Guo Xue Xiang, Chengdu 610041, Sichuan Province, PR China.
Wang X; Department of Neurology, West China Hospital, Sichuan University, No.37 Guo Xue Xiang, Chengdu 610041, Sichuan Province, PR China.
Kong L; Department of Neurology, West China Hospital, Sichuan University, No.37 Guo Xue Xiang, Chengdu 610041, Sichuan Province, PR China.
Chen H; Department of Neurology, West China Hospital, Sichuan University, No.37 Guo Xue Xiang, Chengdu 610041, Sichuan Province, PR China.
Shi Z; Department of Neurology, West China Hospital, Sichuan University, No.37 Guo Xue Xiang, Chengdu 610041, Sichuan Province, PR China. Electronic address: .
Zhou H; Department of Neurology, West China Hospital, Sichuan University, No.37 Guo Xue Xiang, Chengdu 610041, Sichuan Province, PR China. Electronic address: .
Pokaż więcej
Źródło:
Journal of neuroimmunology [J Neuroimmunol] 2024 Mar 15; Vol. 388, pp. 578263. Date of Electronic Publication: 2023 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Neuromyelitis Optica*/diagnosis
Neuromyelitis Optica*/drug therapy
Disabled Persons*
Motor Disorders*
Humans ; Tibet/epidemiology ; Retrospective Studies ; Prognosis ; Recurrence
Czasopismo naukowe
Tytuł:
Global left ventricular myocardial work index and medium-term adverse cardiovascular events after ST-elevation myocardial infarction.
Autorzy:
Timóteo AT; Cardiology Department, Santa Marta Hospital, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal; NOVA Medical School, Lisbon, Portugal. Electronic address: .
Branco LM; Cardiology Department, Santa Marta Hospital, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.
Galrinho A; Cardiology Department, Santa Marta Hospital, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.
Rio P; Cardiology Department, Santa Marta Hospital, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.
Papoila AL; NOVA Medical School, Lisbon, Portugal; Center of Statistics and Its Applications (CEAUL), Lisbon, Portugal; Epidemiology and Statistics Unit, Research Centre, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.
Alves M; NOVA Medical School, Lisbon, Portugal; Center of Statistics and Its Applications (CEAUL), Lisbon, Portugal; Epidemiology and Statistics Unit, Research Centre, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.
Ferreira RC; Cardiology Department, Santa Marta Hospital, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal; NOVA Medical School, Lisbon, Portugal.
Pokaż więcej
Źródło:
International journal of cardiology [Int J Cardiol] 2024 Mar 15; Vol. 399, pp. 131781. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
ST Elevation Myocardial Infarction*/diagnostic imaging
ST Elevation Myocardial Infarction*/complications
Myocardial Infarction*
Percutaneous Coronary Intervention*
Humans ; Male ; Middle Aged ; Female ; Retrospective Studies ; Prospective Studies ; Stroke Volume ; Ventricular Function, Left ; Prognosis
Czasopismo naukowe
Tytuł:
HER2-low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis.
Autorzy:
Lin M; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Breast and Urinary Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Luo T; Breast Disease Center, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.; Multi-Omics Laboratory of Breast Diseases, State Key Laboratory of Biotherapy, National Collaborative, Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Jin Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhong X; Breast Disease Center, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.; Multi-Omics Laboratory of Breast Diseases, State Key Laboratory of Biotherapy, National Collaborative, Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Zheng D; Laboratory of Integrative Medicine, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
Zeng C; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Guo Q; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Wu J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.; Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.
Shao ZM; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.; Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.
Hu X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Breast and Urinary Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Yang W; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhang J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Phase I Clinical Trial Center, Fudan University Shanghai Cancer Center, Shanghai, China.
Pokaż więcej
Źródło:
Cancer [Cancer] 2024 Mar 15; Vol. 130 (6), pp. 851-862. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/genetics
Breast Neoplasms*/therapy
Breast Neoplasms*/metabolism
Humans ; Female ; Receptor, ErbB-2/metabolism ; Cohort Studies ; China ; Prognosis ; Receptors, Progesterone/metabolism
Czasopismo naukowe
Tytuł:
Identification of the prognostic value of LACTB2 and its correlation with immune infiltrates in ovarian cancer by integrated bioinformatics analyses.
Autorzy:
Cao W; Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.; Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.
Wang C; Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.; Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.
Zhang Y; Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.; Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.
Yang J; Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.; Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.
Luo X; Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.; Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.
Zhao Y; Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.; Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.
Wu M; Department of Obstetrics and Gynecology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201204, China.
Cheng S; Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China. .; Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China. .; Department of Obstetrics and Gynecology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201204, China. .
Wang Y; Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China. .; Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China. .
Pokaż więcej
Źródło:
European journal of medical research [Eur J Med Res] 2024 Mar 12; Vol. 29 (1), pp. 166. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*
Humans ; Female ; Prognosis ; Computational Biology ; Immunotherapy ; Kaplan-Meier Estimate ; beta-Lactamases
Czasopismo naukowe
Tytuł:
An increase in SNHG5 expression is associated with poor cancer prognosis, according to a meta-analysis.
Autorzy:
Huang Q; Department of Laboratory Medicine, Hechi Hospital Affiliated to Youjiang Medical University for Nationalities, the People's Hospital of Hechi, Hechi, 547000, Guangxi, China.
Xia YG; Department of Laboratory Medicine, Hechi Hospital Affiliated to Youjiang Medical University for Nationalities, the People's Hospital of Hechi, Hechi, 547000, Guangxi, China.
Huang YJ; Department of Laboratory Medicine, Hechi Hospital Affiliated to Youjiang Medical University for Nationalities, the People's Hospital of Hechi, Hechi, 547000, Guangxi, China.
Qin HF; Department of Oncology, Hechi Hospital Affiliated to Youjiang Medical University for Nationalities, the People's Hospital of Hechi, Hechi, 547000, Guangxi, China.
Zhang QX; Department of Laboratory Medicine, Hechi Hospital Affiliated to Youjiang Medical University for Nationalities, the People's Hospital of Hechi, Hechi, 547000, Guangxi, China.
Wei CF; Department of Laboratory Medicine, Hechi Hospital Affiliated to Youjiang Medical University for Nationalities, the People's Hospital of Hechi, Hechi, 547000, Guangxi, China.
Tang WR; Department of Nuclear Medicine, Hechi Hospital Affiliated to Youjiang Medical University for Nationalities, the People's Hospital of Hechi, Hechi, 547000, Guangxi, China.
Liao Y; Department of Nuclear Medicine, Hechi Hospital Affiliated to Youjiang Medical University for Nationalities, the People's Hospital of Hechi, Hechi, 547000, Guangxi, China. .
Pokaż więcej
Źródło:
European journal of medical research [Eur J Med Res] 2024 Mar 12; Vol. 29 (1), pp. 160. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Neoplasms*/genetics
RNA, Long Noncoding*/genetics
Male ; Humans ; Prognosis ; Proportional Hazards Models ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Tytuł:
Antiphospholipid antibodies as potential predictors of disease severity and poor prognosis in systemic lupus erythematosus-associated thrombocytopenia: results from a real-world CSTAR cohort study.
Autorzy:
Li J; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Ministry of Education, Beijing, 100730, China.
Peng L; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Ministry of Education, Beijing, 100730, China.
Wu L; Department of Rheumatology and Immunology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830001, China.
Ding Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Ministry of Education, Beijing, 100730, China.
Duan X; Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
Xu J; Department of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China.
Wei W; Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, 300052, China.
Chen Z; Department of Rheumatology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, China.
Zhao C; Department of Rheumatology and Immunology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, China.
Yang M; Department of Rheumatic & TCM Medical Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Jiang N; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Ministry of Education, Beijing, 100730, China.
Zhang S; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Ministry of Education, Beijing, 100730, China.
Wang Q; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Ministry of Education, Beijing, 100730, China.
Tian X; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Ministry of Education, Beijing, 100730, China.
Li M; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Ministry of Education, Beijing, 100730, China.
Zeng X; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Ministry of Education, Beijing, 100730, China. .
Zhao Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Ministry of Education, Beijing, 100730, China. zhaoyan_.
Zhao J; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Ministry of Education, Beijing, 100730, China. .
Pokaż więcej
Źródło:
Arthritis research & therapy [Arthritis Res Ther] 2024 Mar 12; Vol. 26 (1), pp. 67. Date of Electronic Publication: 2024 Mar 12.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Lupus Erythematosus, Systemic*
Thrombocytopenia*
Antiphospholipid Syndrome*
Humans ; Antibodies, Antiphospholipid ; Cohort Studies ; Prospective Studies ; Prognosis ; Patient Acuity ; Recurrence
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies